PRAPELA
Prapela is an affordable, noninvasive stimulation therapy that improves newborn health. Our focus is on three clinical problems experienced by thousands of newborns every day. Placed inside a hospital bassinet or incubator, our reusable pad provides gentle stimulation that helps improve the natural processes of breathing control and oxygenation. Since receiving our first award in 2017, Prapela has become America's most-awarded pediatric medical device startup. With over $8M in grants (and hopefully more), we are honored and motivated to work with neonatologists, the National Institutes of Health, and the FDA to improve the health of newborns.
PRAPELA
Industry:
Children Health Care Life Science Therapeutics
Founded:
2017-01-01
Address:
Biddeford, Maine, United States
Country:
United States
Website Url:
http://www.prapela.com
Total Employee:
1+
Status:
Active
Contact:
833-772-7352
Total Funding:
8.23 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Content Delivery Network IPv6 Product Schema Offer Schema COVID-19 Wix Facebook Domain Insights
Similar Organizations
Affinia Therapeutics
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Immunitas Therapeutics
Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.
nference
nference is an Artificial Intelligence (AI)-powered venture creation engine
RightAir
RightAir is developing noninvasive ventilators for COPD patients.
Spotlight Therapeutics
Spotlight Therapeutics is a biotechnology company that develops biologics targeted to specific cell populations in gene editing.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Vitara Biomedical
Vitara Biomedical develops a therapeutic platform to support premature infants.
Zenflow
Zenflow is a medical company that gives new hope to men suffering from BPH symptoms.
Current Employees Featured
Jim Niemi Co-founder & Technical Advisor @ Prapela
Co-founder & Technical Advisor
2017-03-01
David Morrill VP of Product Development @ Prapela
VP of Product Development
2021-05-20
John Konsin CEO & Co-Founder @ Prapela
CEO & Co-Founder
2017-01-01
David Morrill VP of Product Development @ Prapela
VP of Product Development
2021-05-20
Founder
Investors List
Charles Hood Foundation
Charles Hood Foundation investment in Grant - Prapela
National Institutes of Health
National Institutes of Health investment in Grant - Prapela
National Institutes of Health
National Institutes of Health investment in Grant - Prapela
Maine Technology Institute
Maine Technology Institute investment in Grant - Prapela
U.S. Small Business Administration
U.S. Small Business Administration investment in Non Equity Assistance - Prapela
Southern Maine Planning and Development Commission
Southern Maine Planning and Development Commission investment in Non Equity Assistance - Prapela
Massachusetts Life Sciences Center
Massachusetts Life Sciences Center investment in Grant - Prapela
Ohio Third Frontier
Ohio Third Frontier investment in Grant - Prapela
Baylor College of Medicine
Baylor College of Medicine investment in Grant - Prapela
National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA) investment in Grant - Prapela
Official Site Inspections
http://www.prapela.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Prapela"
Home | Prapela Breakthough Stimulation Therapy for Apnea of …
Prapela was created in 2018 by John Konsin after being introduced to the unique technology created by Dr. David Paydarfar and further developed by a team of experienced medical professionals and engineers at Harvard's Wyss Institute for Biologically Inspired Engineering, The University of Massachusetts Medical School, and Massachusetts General Hospital.See details»
Prapela - Crunchbase Company Profile & Funding
Prapela is an affordable, noninvasive stimulation therapy that improves newborn health. Our focus is on three clinical problems experienced by thousands of …See details»
About - Prapela
833-prapela. About Us. We understand more about random stimulation and infant health than any team in the world. It's the result of over 50 years of combined effort to develop and bring to market Prapela's unique stimulation therapy. …See details»
Prapela Company Profile 2024: Valuation, Funding & Investors
Prapela has raised $300K. Who are Prapela’s investors? Maine Department of Economic and Community Development , MedTech Innovator , University of New Hampshire School of Law Endowment, Maine Technology Institute , and United States Small Business Administration are 5 of 16 investors who have invested in Prapela.See details»
Prapela - Funding, Financials, Valuation & Investors - Crunchbase
Prapela is a noninvasive stimuation therapy that improves breathing and oxygenation in newborns. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead InvestorsSee details»
Prapela Company Profile - Office Locations, Competitors ... - Craft
Prapela has 5 employees at their 1 location. See insights on Prapela including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Prapela, Inc. Company Profile | Biddeford, ME - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Prapela, Inc. of Biddeford, ME. Get the latest business insights from Dun & Bradstreet.See details»
Prapela's Leadership Team Team - Team members and org chart
The leadership team at Prapela has experience in various engineering and product development fields from companies such as MODA Electronics, Wentworth Technology, National Semiconductor, and Afferent Corporation. They also have experience as startup advisors and board members for companies such as Wyss Institute for Biologically Inspired ...See details»
Prapela wins NIH funding for newborn apnea treatment device
Sep 6, 2023 A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS. A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. ... Infant health company Prapela has received a grant from the National Institutes of ...See details»
Prapela Company Profile - MedTech Innovator
Prapela's incubator pad is the first innovation to improve the treatment of apnea of prematurity in over twenty years. Open Menu. About. ... MedTech Innovator is a 501(c)(3) nonprofit organization and the largest accelerator of medical technology companies in the world. Our mission is to improve the lives of patients by accelerating the growth ...See details»
Prapela - Contacts, Employees, Board Members, Advisors & Alumni
Prapela is a noninvasive stimuation therapy that improves breathing and oxygenation in newborns.See details»
Prapela receives NIH Grant to improve the treatment of Apnea of ...
BIDDEFORD, Maine, April 6, 2023 /PRNewswire/ -- Prapela, Inc., an infant health company in Biddeford, ME, was awarded a grant through the National Institutes of Health (NIH) Blueprint MedTech program and National Institute on Drug Abuse (NIDA), to support the development and evaluation of Prapela's pad to treat apnea in preterm newborns in collaboration with …See details»
Stimulation Therapy For Newborns - WISH
Prapela’s mission is to add a new capability to the thousands of incubators used around the world every day, replacing standard pads with Prapela’s innovation. More importantly, Prapela is introducing the first innovation to significantly improve the care for preterm newborns with AOP and the outcome of their condition in over twenty years. ...See details»
Prapela Receives FDA's Breakthrough Device Designation to …
Jan 5, 2023 Prapela’s stimulation pad could become available sooner as a new treatment option for preterm newborns experiencing apnea. BIDDEFORD, Maine, ... MedTech Innovator is a 501(c)(3) nonprofit organization and the largest accelerator of medical technology companies in the world. Our mission is to improve the lives of patients by accelerating the ...See details»
Technology - Prapela
As a result, normal breathing patterns are interrupted, and low blood oxygen levels can occur. Since 1995, random stimulation has demonstrated improved breathing rhythm and lung performance in newborns. Prapela is advancing the use of stochastic stimulation in everyday practice to improve infant health.See details»
PRAPELA RECEIVES FDA'S BREAKTHROUGH DEVICE DESIGNATION …
Jan 5, 2023 Prapela's device is a mattress pad producing a unique vibration that boosts the brain's control of breathing. Placed inside an incubator, radiant warmer, or hospital bassinet, preterm infants ...See details»
Awards - Prapela
Prapela received our 2nd FDA Breakthrough Device Designation on January 3, 2023. The award accelerates our work in Apnea of Prematurity. On October 23, 2022, Prapela's innovation for Apnea of Prematurity (AOP) took 1st place in the FDA-sponsored NCC-PDI program.See details»
Advancing Infant Health with Prapela Cofounder John Konsin
Oct 22, 2024 John Konsin, co-founder and CEO of Prapela, is introducing groundbreaking technology to help newborns breathe better during their first three months of life....See details»
Applications - Prapela
Info@prapela.com 833-772-7352. 833-prapela. Clinical Applications. Our focus is on three clinical problems experienced by thousands of newborns every day. Placed in a hospital bassinet or incubator, our gentle stimulation helps improve the natural …See details»
Research & Grants | Prapela
"Prapela pad: A cost-effective stochastic vibrotactile device to improve the clinical course of preterm infants with intermittent hypoxemia.," was recently submitted as a Fast-Track grant to the NIH. The project will complete the development and establish the safety, efficacy, and clinical benefit of a low-cost stochastically vibrating pad to reduce hypoxemic episodes in preterm …See details»